ImmunoGenesis

ImmunoGenesis is a biotechnology company based in Houston, Texas. The company employs 12 people and generates $5 million in annual revenue. ImmunoGenesis specializes in developing immune therapies for tumors that lack activated T cells or exhibit immune resistance mechanisms. These "cold" tumors, which comprise the majority of cancers, pose a significant challenge to traditional immunotherapy approaches. The company's focus is on creating sophisticated therapies that address the specific mechanisms underlying immune resistance in these tumors. ImmunoGenesis distinguishes itself through its science-driven approach to drug development. The company's team of experts leverages a deep understanding of cold tumor pathology to design targeted therapies that overcome immune resistance and unlock the potential for effective treatment. For more information about ImmunoGenesis and its innovative immune therapies, please visit immunogenesis.com.